CIPACA partners with ImpactGuru.com to offer financial services to patients in rural areas

Emergency healthcare provider CIPACA has entered into a collaboration with ImpactGuru.com to help patients living in rural areas avail of financial services for their treatment, the firm said. Chennai Interventional Pulmonology and Critical Care...

Allurion launches its world-leading weight management solution in India

Allurion, a firm dedicated to ending obesity, has launched the Allurion Swallowable Capsule in India - the only medical weight-loss device fully approved by the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority..

TraceX collaborates with CannSol to offer traceable nutraceuticals

TraceX Technologies has partnered with Liechtenstein-based CannSol. Through this collaboration with TraceX, CannSol will offer traceability of each ingredient at every stage of the production of the product...

1mg turns unicorn after latest funding led by Tata Digital

Online pharmacy 1mg has entered the unicorn club after an internal funding round led by Tata Digital, sources briefed on the matter said...

Three benefits of Health technology assessment in the healthcare industry

It does not need to be said that health care resources are limited and that there are many more interventions that provide benefits to patients than society can afford.

Indian pharma market grew 12.1% in value during August

Indian pharmaceutical market (IPM) grew 12.1% in value and 4.8% in volumes, in the month of August on back of strong growth across all the therapy areas, according to a research...

Cipla, JB Chemicals & Torrent lead Rs 4,500-crore race for Medley Pharma

Cipla, KKR-owned JB Chemicals and Torrent Pharmaceuticals are in the final race for acquiring Medley Pharmaceuticals in a deal worth around ₹4,500 crore, said people aware of the development. Half a dozen bids were in for Medley, including bids...

Frederic Oudea to be Sanofi's non-executive chairman

The appointment of Societe Generale's boss Frederic Oudea as non-executive chairman of Sanofi will be proposed at the next shareholders meeting of the French drugs group, Sanofi said....

UK approved second 'bivalent' booster for Omicron & original COVID strain

The UK health authorities approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19...

Three Crucial Benefits of Leveraging Real-World Evidence in Pharma

RWE helps researchers understand how patient characteristics and behaviors affect health outcomes, which helps to predict the progression of a disease and a patient’s response to a vaccine or therapy.

© 2025 India Pharma Outlook. All Rights Reserved.